Form 4: Inari Medical CFO Mitch Hill Executes Stock Options and Sells Shares Under 10b5-1 Plan

Mitch C. Hill, CFO of Inari Medical, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 12, 2024, Mitch C. Hill, the Chief Financial Officer of Inari Medical, Inc., exercised stock options to acquire 6,000 shares of common stock at a price of $0.457 per share.
• Simultaneously, Hill sold 5,999 shares of common stock at a weighted average price of $41.91, with prices ranging from $41.41 to $42.32.
• An additional single share was sold at $42.58.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 9, 2023.
• Following these transactions, Hill directly owns 183,361 shares of Inari Medical common stock and indirectly owns 1,600 shares through his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to monitor.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The impact is likely minimal given the transactions are part of a pre-arranged trading plan.

Key Dates